Evaluation of Oxygen Therapy Delivery Systems in Hypoxemic Acute Respiratory Failure
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Acute Respiratory Failure
- Sponsor
- Nantes University Hospital
- Enrollment
- 16
- Locations
- 1
- Primary Endpoint
- Calcul of the ratio PaO2/FiO2
- Status
- Terminated
- Last Updated
- 12 years ago
Overview
Brief Summary
The main objective of this study is to evaluate the efficiency of the oxygen therapy delivery system Optiflow® compared to 2 others standard oxygen therapy delivery systems (Ospal®, non invasive ventilation).12 immunocompetent patients will compare the successive use of oxygen therapy delivery systems Optiflow®/Ospal® and 12 immunodeficient patients will compare the successive use of systems Optiflow®/Non invasive ventilation.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patient hospitalized in the intensive care unit of Nantes University Hospital
- •Signed informed consent
- •Patient with not hypercapnic acute hypoxemic respiratory failure
- •Immunocompetent and immunodeficient patient
Exclusion Criteria
- •Age \< 18 years
- •Pregnancy
- •Contra-indication to non invasive ventilation
- •Allergy to xylocaine
- •Coagulation troubles
- •Tracheotomized patient
- •Urgent indication to intubation
- •Hypercapnic acute respiratory failure
- •Acute pulmonary edema
- •Face or nose malformation
Outcomes
Primary Outcomes
Calcul of the ratio PaO2/FiO2
Time Frame: one hour after each system used
The main objective of this study is to evaluate the efficiency of the oxygen therapy delivery system Optiflow® compared to 2 others standard oxygen therapy delivery systems (Ospal®, non invasive ventilation) by calculating the ratio PaO2/FiO2
Secondary Outcomes
- number of participants with adverse events
- measure of respiratory frequency and blood gas
- measure of positive and expiratory pressure